About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials | 4,039 Studies Recruiting

Clinical TrialsOvarian Cancer

Ovarian Cancer Clinical Trials

Browse 4,039 clinical trials for ovarian cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2221-2240 of 4,039 trials

RecruitingStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Combination with Anticancer…NCT05489211·Los Angeles, California and 95 others

Related Searches

ovary cancertrials

Data from ClinicalTrials.govTerms

CompletedCapecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004012·New York, New York

CompletedEfficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian CancerPhase II, two arm prospective study of efficacy and safety of ELENAGEN in combination with gemcitabine in comparison with gemcitabine alone in patients with platinum-resistant…NCT05979298·Minsk

Active not recruitingAn Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian CancerTo evaluate the remission effect and safety of intravenous injection of METR-NK cells as adjuvant therapy on bone marrow suppression in patients with ovarian cancer after…NCT07096583·Hefei, Anhui

CompletedHigh-dose ICE With AmifostineThe purpose of the study is to evaluate the combination of amifostine and high dose chemotherapy with blood stem cell support.NCT00003657·Boston, Massachusetts and 2 others

CompletedGM-CSF, Sargramostim in Women With Recurrent Ovarian CancerGranulocyte macrophage colony-stimulating factor (GM-CSF) is an immunostimulant and preliminary data suggests it may change the natural history of prostate cancer and melanoma.NCT00157573

CompletedReal-life Data of Olaparib in Relapsed Ovarian Cancers PatientsThis is a national, multi center, retrospective observational cohort study that will be carried out by reviewing the medical records of patients with relapsed epithelial ovarian…NCT04152941·Angers and 27 others

RecruitingLead-212 PSV359 Therapy for Patients With Solid TumorsPhase I/IIa image-guided, alpha-particle therapy study of \[203Pb\]Pb-PSV359 and \[212Pb\]Pb-PSV359 in patients with solid tumors that are known to be Fibroblast Activation…NCT06710756·Miami, Florida and 10 others

CompletedCharacterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCAThe multi-centered, cross-sectional investigations shall be conducted in this study with the objective of identifying the ownership ratio of gBRCAm on the newly diagnosed patients…NCT03229122·Aichi and 34 others

WithdrawnNiraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian CancerThis phase I/II trial tests the safety, side effects and best dose of a combination therapy (niraparib and selenium) in treating patients with BRCA negative ovarian cancer that…NCT05672095

CompletedFlaxseed as Maintenance Therapy for Ovarian Cancer Patients in RemissionThis is a phase 0/phase I feasibility trial to test the hypothesis that flaxseed supplementation is an effective maintenance therapy for patients with ovarian cancer who are in…NCT02324439·Springfield, Illinois

CompletedBIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal CancerThis phase I, open label dose escalation study will investigate the addition of BIBF 1120 to treatment with the combination of carboplatin and Pegylated Liposomal Doxorubicin…NCT01314105·Barcelona and 2 others

CompletedPlatinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00002894·London, England

CompletedStandard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age ChildrenRATIONALE: A study that evaluates the support of a decision guide used together with genetic counseling may improve communication between mothers undergoing BRCA1/2 testing and…NCT00685256·Washington D.C., District of Columbia and 1 other

CompletedTiming of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerRATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00075712·Aylesbury-Buckinghamshire, England and 69 others

CompletedPrediction of Platinum Resistance and Prognosis of High-grade Serous Ovarian CancerHigh-grade serous ovarian carcinoma (HGSOC) is the most common subtype of ovarian carcinoma.NCT06787170·Kunming, Yunnan

CompletedEfficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic CancerTo compare the incidence of lymphocele and lymphatic ascites between patient who use versus who do not use FloSeal during lymph node dissectionNCT01679483·Seoul

CompletedEvaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CarcinomaThe purpose of this study is to evaluate the safety and efficacy of TRC105 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.NCT01381861·Birmingham, Alabama and 6 others

Active not recruitingSafety and Tolerability of IPH4502 in Patients With Advanced Solid TumorsThis is a first-in-human, open-label, multicenter, Phase 1 study to evaluate the safety, tolerability and preliminary efficacy of IPH4502 and to determine the recommended Phase 2…NCT06781983·Boston, Massachusetts and 6 others

UnknownDensity Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)DELFINO tial is designed to investigate the role of "OFS add on to TMX ", based on MMG density as a surrogate marker in premenopausal women * Premise - MMG density as a surrogate…NCT03664895·Seoul

PreviousPage 112 of 202Next